Checkpoint inhibitors and myeloma: promises, deadlocks and new directions.

ABSTRACT:

SUBMITTER: Bertamini L 

PROVIDER: S-EPMC7333157 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature